Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Controlled microflora in animals delays immune cell maturation and affects immunity.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Candida antigen is an effective and promising treatment for alopecia areata.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Adalimumab helped control a child's severe eye disease when other treatments failed.

FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A group has developed therapies that show promise for treating cancer and various other conditions.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.